Theravance Biopharma shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Theravance Biopharma by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $53k | 3.6k | 14.60 |
| 2025-06-30 | $40k | 3.6k | 11.03 |
| 2025-03-31 | $32k | 3.6k | 8.93 |
| 2024-12-31 | $34k | 3.6k | 9.41 |
| 2024-09-30 | $29k | 3.6k | 8.06 |
| 2024-06-30 | $31k | 3.6k | 8.48 |
| 2024-03-31 | $55k | 6.1k | 8.97 |
| 2023-12-31 | $68k | 6.1k | 11.24 |
| 2023-09-30 | $53k | 6.1k | 8.63 |
| 2023-06-30 | $48k | 4.6k | 10.35 |
| 2023-03-31 | $50k | 4.6k | 10.85 |
| 2022-12-31 | $51k | 4.6k | 10.90 |
| 2022-09-30 | $47k | 4.6k | 10.14 |
| 2022-06-30 | $42k | 4.6k | 9.06 |
| 2022-03-31 | $44k | 4.6k | 9.49 |
| 2021-12-31 | $51k | 4.6k | 11.00 |
| 2021-09-30 | $28k | 3.8k | 7.38 |
| 2021-06-30 | $55k | 3.8k | 14.50 |
| 2021-03-31 | $77k | 3.8k | 20.30 |
| 2020-12-31 | $76k | 4.3k | 17.75 |
| 2020-09-30 | $63k | 4.3k | 14.71 |
| 2020-06-30 | $90k | 4.3k | 21.02 |
| 2020-03-31 | $92k | 4.0k | 23.16 |
| 2019-12-31 | $95k | 3.7k | 25.91 |
| 2019-09-30 | $71k | 3.7k | 19.37 |
| 2019-06-30 | $60k | 3.7k | 16.37 |
| 2019-03-31 | $83k | 3.7k | 22.64 |
| 2018-12-31 | $94k | 3.7k | 25.64 |
| 2018-09-30 | $120k | 3.7k | 32.73 |
| 2018-06-30 | $83k | 3.7k | 22.64 |
| 2018-03-31 | $89k | 3.7k | 24.28 |
| 2017-12-31 | $932k | 3.9k | 241.21 |
| 2017-09-30 | $117k | 3.9k | 30.15 |
| 2017-06-30 | $136k | 3.9k | 35.18 |
| 2017-03-31 | $128k | 3.6k | 35.09 |
| 2016-12-31 | $7.0k | 228 | 30.70 |
| 2016-09-30 | $8.0k | 228 | 35.09 |
| 2016-06-30 | $5.0k | 228 | 21.93 |
| 2016-03-31 | $4.0k | 228 | 17.54 |
| 2015-12-31 | $3.0k | 228 | 13.16 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors